• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Lessons Learned from CDC's Global COVID-19 Early Warning and Response Surveillance System

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Oct;28(13):8-16.
doi: 10.3201/eid2813.212544.
Lessons Learned from CDC's Global COVID-19 Early Warning and Response Surveillance System

Philip M Ricks, Gibril J Njie, Fatimah S Dawood, Amy E Blain, Alison Winstead, Adebola Popoola, Cynthia Jones, Chaoyang Li, James Fuller, Puneet Anantharam, Natalie Olson, Allison Taylor Walker, Matthew Biggerstaff, Barbara J Marston, Ray R Arthur, Sarah D Bennett, Ronald L Moolenaar

Abstract

Early warning and response surveillance (EWARS) systems were widely used during the early COVID-19 response. Evaluating the effectiveness of EWARS systems is critical to ensuring global health security. We describe the Centers for Disease Control and Prevention (CDC) global COVID-19 EWARS (CDC EWARS) system and the resources CDC used to gather, manage, and analyze publicly available data during the prepandemic period. We evaluated data quality and validity by measuring reporting completeness and compared these with data from Johns Hopkins University, the European Centre for Disease Prevention and Control, and indicator-based data from the World Health Organization. CDC EWARS was integral in guiding CDC's early COVID-19 response but was labor-intensive and became less informative as case-level data decreased and the pandemic evolved. However, CDC EWARS data were similar to those reported by other organizations, confirming the validity of each system and suggesting collaboration could improve EWARS systems during future pandemics.

Keywords: COVID-19; Centers for Disease Control and Prevention; Early Warning and Response Surveillance; SARS; SARS-CoV-2; United States; World Health Organization; coronavirus; coronavirus disease; public health surveillance; respiratory infections; severe acute respiratory syndrome coronavirus 2; validation study; viruses; zoonoses.
 
Back
Top Bottom